Welcome to the international HTA database

Showing [18637 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2002	Centre for Clinical Effectiveness (CCE)	Tourniquets in phlebotomy
1998	Health Council of the Netherlands Gezondheidsraad (GR)	Toward the effective use of benzodiazepines
2015	NIHR Health Services and Delivery Research programme	Towards a framework for enhancing procurement and supply chain management practice in the NHS: lessons for managers and clinicians from a synthesis of the theoretical and empirical literature
2013	NIHR Health Services and Delivery Research programme	Towards a framework for enhancing the performance of NHS boards: a synthesis of the evidence about board governance, board effectiveness and board development
2015	Belgian Health Care Knowledge Centre (KCE)	Towards a guided and phased introduction of high-risk medical devices in Belgium
2008	Health Council of the Netherlands Gezondheidsraad (GR)	Towards an adequate intake of vitamin A
2008	Health Council of the Netherlands Gezondheidsraad (GR)	Towards an adequate intake of vitamin D
2009	Health Council of the Netherlands Gezondheidsraad (GR)	Towards an adequate intake of vitamins and minerals
2008	Health Council of the Netherlands Gezondheidsraad (GR)	Towards an optimal use of folic acid
2004	NIHR Health Technology Assessment programme	Towards efficient guidelines: 1. When to develop guidelines- systematic review
2003	NIHR Health Technology Assessment programme	Towards efficient guidelines: how to monitor guideline use in primary care
2013	NIHR Health Services and Delivery Research programme	Towards equitable commissioning for our multiethnic society: a mixed-methods qualitative investigation of evidence utilisation by strategic commissioners and public health managers
2005	NIHR Health Technology Assessment programme	Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis
2016	NIHR Health Services and Delivery Research programme	Towards improved decision support in the assessment and management of pain for people with dementia in hospital: a systematic meta-review and observational study
2008	Health Council of the Netherlands Gezondheidsraad (GR)	Towards maintaining an optimum iodine intake
2010	NIHR Health Technology Assessment programme	Towards single embryo transfer? Modelling clinical outcomes of potential treatment choices using multiple data sources: predictive models and patient perspectives
2010	HAYES, Inc.	Townes-Brocks Syndrome (TBS)
2011	HAYES, Inc.	TP53 (p53) testing for Li-Fraumeni Syndrome (LFS)
2012	HAYES, Inc.	TP63-related disorders (ectrodactyly-ectodermal dysplasia-clefting [EEC3] syndrome; acro-dermato-ungual-lacrimal-tooth [ADULT] syndrome; ankyloblepharon-ectodermal dysplasia-clefting [AEC; hay-wells] syndrome; limb-mammary syndrome (LMS); nonsyndromic split-hand/split-foot malformation [SHFM4]; rapp-hodgkin syndrome [RHS])
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Trabectedin (Yondelis) for advanced and/or metastatic translocation-related sarcomas - first line
2007	NIHR Horizon Scanning Centre (NIHR HSC)	Trabectedin (Yondelis) for relapsed ovarian cancer
2006	NIHR Horizon Scanning Centre (NIHR HSC)	Trabectedin (Yondelis) for second and third-line treatment of soft tissue sarcoma: horizon scanning technology ultra-orphan note
2010	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Trabectedin (Yondelis) for second-line recurrent platinum-sensitive ovarian cancer
2008	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Trabectedin (Yondelis®) for advanced soft tissue sarcoma
2003	NIHR Horizon Scanning Centre (NIHR HSC)	Trabectedin for soft tissue sarcoma - horizon scanning review
2010	NIHR Health Technology Assessment programme	Trabectedin for the treatment of advanced metastatic soft tissue sarcoma
2010	National Institute for Health and Clinical Excellence (NICE)	Trabectedin for the treatment of advanced soft tissue sarcoma
2011	NIHR Health Technology Assessment programme	Trabectedin for the treatment of relapsed ovarian cancer
2011	National Institute for Health and Clinical Excellence (NICE)	Trabectedin for the treatment of relapsed ovarian cancer
2009	HAYES, Inc.	Trabectome (NeoMedix Corp.) for treatment of glaucoma
2021	Center for Evidence-based Practice (CEP)	Tracheostomy or endotracheal tubes and subglottic suctioning
2014	HAYES, Inc.	Tracleer (Bosentan; Actelion Pharmaceuticals Ltd.) for treatment of digital ulcers in patients with scleroderma
2002	NIHR Health Technology Assessment programme	Training for patient and public ('consumer') involvement in health and social care research: a study of training provision and participants' experiences
2018	NIHR Health Technology Assessment programme	Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCT
2002	Agency for Healthcare Research and Quality (AHRQ)	Training of clinicians for public health events relevant to bioterrorism preparedness
2004	Agency for Healthcare Research and Quality (AHRQ)	Training of hospital staff to respond to a mass casualty incident
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tramadol compared with opioids for pain: a review of addiction potential
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tramadol for the management of pain in adult patients: clinical effectiveness and guidelines
2012	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Trametinib for advanced or metastatic BRAF V600E mutation-positive melanoma
2012	NIHR Horizon Scanning Centre (NIHR HSC)	Trametinib in combination with dabrafenib for V600 BRAF positive advanced malignant melanoma – first line
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tranexamic acid for the management of bleeding: a review of the clinical effectiveness and guidelines
2019	NIHR Health Technology Assessment programme	Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT
2002	New Zealand Health Technology Assessment (NZHTA)	Trans-gender reassignment surgery
2013	HAYES, Inc.	Transabdominal Cervical Cerclage (TAC) for the prevention of miscarriage
2004	Medical Services Advisory Committee (MSAC)	Transanal endoscopic microsurgery
2007	HAYES, Inc.	Transanal endoscopic microsurgery for rectal carcinoma
2009	HAYES, Inc.	Transanal endoscopic microsurgery for rectal carcinoma
2013	HAYES, Inc.	Transanal hemorrhoidal dearterialization
2010	HTA Database, Centre for Reviews and Dissemination, University of York	Transarterial chemoembolization for palliation of unresectable liver metastases from colorectal cancer (Protocol for a systematic review)
2012	HAYES, Inc.	Transarterial chemoembolization plus radiofrequency ablation for liver cancer
2013	HAYES, Inc.	Transarterial embolization with embozene microspheres (CeloNova BioSciences Inc.) for treatment of hepatocellular carcinoma and other liver tumors
2012	HAYES, Inc.	Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2012	New Zealand National Health Committee (NHC)	Transcatheter Aortic Valve Implantation (TAVI) - briefing report
2009	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Transcatheter Aortic Valve Implantation (TAVI) at the MUHC: a Health Technology Assessment
2011	Scottish Health Technologies Group (SHTG)	Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults
2014	Scottish Health Technologies Group (SHTG)	Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults at high surgical risk
2014	Scottish Health Technologies Group (SHTG)	Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery
2011	Scottish Health Technologies Group (SHTG)	Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults. This evidence note updates evidence note 33 published in March 2011
2020	Health Technology Wales (HTW)	Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk
2013	Medical Advisory Secretariat (MAS)	Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update
2012	Medical Advisory Secretariat (MAS)	Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B)
2019	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2018	European Network for Health Technology Assessment (EUnetHTA)	Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk
2013	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis. Update of Report No. 45
2021	Norwegian Institute of Public Health (NIPH)	Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment
2011	Belgian Health Care Knowledge Centre (KCE)	Transcatheter aortic valve implantation (TAVI): an updated health technology assessment
2012	HAYES, Inc.	Transcatheter aortic valve implantation for aortic stenosis
2013	HAYES, Inc.	Transcatheter aortic valve implantation for aortic stenosis
2011	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve implantation for aortic stenosis: a review of the clinical effectiveness and guidelines
2013	Health Quality Ontario (HQO)	Transcatheter aortic valve implantation for the treatment of aortic valve stenosis: an evidence update
2016	Health Quality Ontario (HQO)	Transcatheter aortic valve implantation for treatment of aortic valve stenosis: a health technology assessment
2016	Health Quality Ontario (HQO)	Transcatheter aortic valve implantation for treatment of aortic valve stenosis: OHTAC recommendation
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment
2015	Medical Services Advisory Committee (MSAC)	Transcatheter aortic valve implantation via transfemoral or transapical delivery
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve implantation: a critical appraisal of a health technology assessment and comparison with a rapid review
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2006	Haute Autorite de sante (HAS)	Transcatheter closure of a patent foramen ovale
2003	Canadian Coordinating Office for Health Technology Assessment (CCOHTA)	Transcatheter closure of atrial septal defects
2013	Medical Services Advisory Committee (MSAC)	Transcatheter closure of patent ductus arteriosus
2017	HAYES, Inc.	Transcatheter closure of prosthetic aortic or mitral paravalvular leaks
2002	HAYES, Inc.	Transcatheter closure of septal defects
2008	HAYES, Inc.	Transcatheter closure of ventricular septal defects
2010	National Institute for Health and Clinical Excellence (NICE)	Transcatheter endovascular closure of perimembranous ventricular septal defect
2016	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation
2014	Medical Services Advisory Committee (MSAC)	Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2015	HAYES, Inc.	Transcatheter surgical valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for aortic stenosis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcendental meditation for posttraumatic stress disorder, depression, and anxiety: a review of clinical effectiveness
2007	HAYES, Inc.	Transconjunctival sutureless vitrectomy using the Millennium TSV25 system (Bausch&Lomb Inc.)
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Transcranial direct current stimulation (tDCS) for Alzheimer's disease
2009	NIHR Horizon Scanning Centre (NIHR HSC)	Transcranial direct current stimulation (tDCS) for major depressive disorder
2017	HAYES, Inc.	Transcranial direct current stimulation for depression
2014	HAYES, Inc.	Transcranial direct current stimulation for depression
2013	Malaysian Health Technology Assessment (MaHTAS)	Transcranial Doppler (TCD) ultrasound and cerebral computed tomography perfusion (CTP) for aneurysmal subarachnoid haemorrhage (SAH)
2009	Institute for Clinical Effectiveness and Health Policy (IECS)	Transcranial doppler ultrasonography: main clinical applications
2015	The Regional Health Technology Assessment Centre (HTA-centrum)	Transcranial Magnetic Resonance Guided Focused Ultrasound treatment of essential tremor, neuropathic pain and Parkinson's disease
2016	Adelaide Health Technology Assessment (AHTA)	Transcranial magnetic resonance-guided focused ultrasound and deep brain stimulation for refractory depression
2010	VA Technology Assessment Program (VATAP)	Transcranial magnetic stimulation (TMS) for depression